Tax-driven ADS sale by BeOne Medicines (ONC) R&D chief disclosed
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
BeOne Medicines Ltd. President and Global Head of R&D Wang Lai reported a small sale of 1,068 American Depositary Shares of the company. The shares were sold at $276.735 per ADS and the transaction is described as an open-market sale.
According to a footnote, this sale was carried out under a mandatory tax withholding provision tied to the vesting of a restricted share unit award that began vesting on June 22, 2022. Each ADS represents 13 ordinary shares.
After these transactions, Wang Lai holds 1,681,004 ordinary shares directly and 601,965 ordinary shares indirectly. Additional RMB Shares are held through structures such as Wang Holdings LLC and an RMB Shares Employee Participation Plan, where he has only indirect economic interest and explicitly disclaims Section 16 beneficial ownership beyond any pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Small, tax-related insider sale that appears routine in scale.
The filing shows Wang Lai sold 1,068 ADS at $276.735 each. A footnote states the sale was executed under a mandatory tax withholding provision linked to vesting of a restricted share unit award, indicating a mechanistic tax event rather than a discretionary sale.
Post‑transaction, he still directly owns 1,681,004 ordinary shares and indirectly owns 601,965 ordinary shares, plus an economic interest in RMB Shares via an employee participation plan. Relative to these positions, the ADS sale is minor and looks like routine compensation‑related housekeeping rather than a signal of changing sentiment.
Insider Trade Summary
Net Seller: 1,068 shares ($295,553)
Net Sell
4 txns
Insider
Wang Lai
Role
President, Global Head of R&D
Sold
1,068 shs ($296K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | American Depositary Shares | 1,068 | $276.735 | $296K |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | RMB Shares | -- | -- | -- |
Holdings After Transaction:
American Depositary Shares — 0 shares (Direct, null);
Ordinary Shares — 1,681,004 shares (Direct, null);
Ordinary Shares — 601,965 shares (Indirect, See Footnote);
RMB Shares — 0 shares (Indirect, See Footnote)
Footnotes (1)
- These securities are held by Wang Holdings LLC, the limited liability company interests of which are owned by the Reporting Person, his spouse and a trust created by the Reporting Person for the benefit of his spouse and children, for which the Reporting Person disclaims beneficial ownership. The term "RMB Shares" is used herein to represent the ordinary shares, par value $0.0001 per share, of the Issuer, issued directly by the Issuer in the Issuer's initial public offering on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange (the "STAR Offering"), to permitted investors in Renminbi ("RMB") within the People's Republic of China ("PRC") in accordance with the rules of the STAR Market. The Issuer established an employee participation program ("RMB Shares Employee Participation Plan"), which allows certain executive officers and qualified employees of the Issuer's subsidiaries in the PRC to indirectly participate in the STAR Offering and purchase certain RMB Shares from the Issuer through an asset management plan administrated by China International Capital Corporation Limited in a transaction that is exempt under Rule 16b-3. The RMB Share Employee Participation Plan purchased an aggregate of 2,069,546 RMB Shares directly from the Issuer in the STAR Offering at the initial public offering price of RMB192.6 per RMB Share (or $30.1295 based on an assumed exchange rate of $1.00 = RMB6.3924). The Reporting Person, as an individual participant in the RMB Shares Employee Participation Plan, has contributed RMB10 million to the RMB Shares Employee Participation Plan. The Reporting Person may be deemed to have indirect economic interest in an indeterminable portion of the RMB Shares held by the RMB Shares Employee Participation Plan but does not have voting or dispositive power over any of such shares. The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan, except to the extent, if any, of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such RMB Shares for Section 16 or any other purpose. Each American Depositary Share represents 13 Ordinary Shares. The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 22, 2022, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
Key Figures
ADS sold: 1,068 ADS
Sale price per ADS: $276.735 per ADS
Direct ordinary shares held: 1,681,004 ordinary shares
+5 more
8 metrics
ADS sold
1,068 ADS
Open-market sale on 2026-06-23
Sale price per ADS
$276.735 per ADS
Tax-related sale linked to RSU vesting
Direct ordinary shares held
1,681,004 ordinary shares
Direct ownership after transactions
Indirect ordinary shares held
601,965 ordinary shares
Indirect ownership after transactions
RMB plan purchase size
2,069,546 RMB Shares
Purchased by employee participation plan in STAR IPO
RMB IPO price
RMB192.6 per RMB Share
STAR Market initial public offering price
USD equivalent IPO price
$30.1295 per RMB Share
Based on exchange rate $1.00 = RMB6.3924
ADS to ordinary share ratio
1 ADS = 13 ordinary shares
BeOne Medicines depositary share structure
Key Terms
RMB Shares Employee Participation Plan, Section 16 beneficial ownership, restricted share unit award, mandatory tax withholding, +2 more
6 terms
Section 16 beneficial ownership regulatory
"The Reporting Person disclaims Section 16 beneficial ownership of the RMB Shares held by the RMB Shares Employee Participation Plan..."
mandatory tax withholding financial
"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement..."
STAR Market financial
"initial public offering on the Science and Technology Innovation Board (the "STAR Market") of the Shanghai Stock Exchange..."
A Star Market is a specialized segment of a stock exchange designed to list fast-growing, technology- or innovation-focused companies under rules intended to make it easier for startups and research-driven firms to raise capital. For investors it matters because it provides a way to access potentially high-growth opportunities that come with higher risk and volatility—like buying early-stage products at a startup fair rather than established brands at a supermarket.
FAQ
What insider transaction did BeOne Medicines (ONC) report for Wang Lai?
BeOne Medicines reported that executive Wang Lai sold 1,068 American Depositary Shares at a price of $276.735 per ADS. The filing describes it as an open‑market sale tied to a mandatory tax withholding provision in his restricted share unit award agreement.
Why did BeOne Medicines executive Wang Lai sell 1,068 ADS of ONC?
The sale was executed pursuant to a mandatory tax withholding provision in Wang Lai’s restricted share unit award agreement. It covered taxes due when a prior restricted share unit grant vested, making the transaction compensation‑related rather than a discretionary portfolio sale.